Yahoo Web Search

Search results

    • Roche (RHHBY) Reports Upbeat Data on Columvi From STARGLO Study

      Zacks· 15 hours ago

      ..., multicentre, open-label, randomized study evaluating the efficacy and safety of Columvi, in combination with gemcitabine plus oxaliplatin (GemOx), versus MabThera/Rituxan (rituximab), in combination with GemOx (R-GemOx), in patients with relapsed or refractory (R/R) diffuse large B-cell...

  1. Related searches

    fecal transplant deaths